13569.rar [BEST]

Research into PRAME as an immunotherapy target in sarcoma subtypes.

If you can specify whether you are looking for or genetic sequencing data from this file, I can provide more precise information. 13569.rar

Immune checkpoint inhibitors in sarcomas: a systematic review Research into PRAME as an immunotherapy target in

This research, likely part of the dataset, analyzed tumor sequencing to identify the amplification of genes such as MDM2 and CDK4 in 12q14-15. It connects these molecular findings to survival and metastasis rates in patients, noting that MDM2 amplification is a key marker distinguishing DDLPS from benign tumors. It connects these molecular findings to survival and

Studies on how combinations of drugs (like TKIs and anti-CTLA-4) treat sarcoma, particularly Alveolar Soft Part Sarcoma.

Other related research topics often found in similar databases include:

Analysis of DNA methylation patterns affecting chemo-resistance in sarcoma patients.